SANTHERA PHARMACEUTICALS HOLDING AG |
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 9.21 CHF | +0.77% |
|
-0.99% | -7.85% |
| 04-25 | Transcript : Santhera Pharmaceuticals Holding AG, 2023 Earnings Call, Apr 25, 2024 | |
| 04-25 | Santhera Pharmaceuticals Swings to Profit in FY23; Revenue Grows | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Specialty & Advanced Pharmaceuticals
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 114M | - | - | - | - | ||
| 72.5B | ||||||
| 9.11B | ||||||
| 5.07B | ||||||
| 5.01B | - | - | ||||
| 3.85B |
